Evidence Details for TAGLN3


Gene Symbol: | TAGLN3 ( NP22,NP25 ) |
---|---|
Gene Full Name: | transgelin 3 |
Band: | 3q13.2 |
Quick Links | Entrez ID:29114; OMIM: 607953; Uniprot ID:TAGL3_HUMAN; ENSEMBL ID: ENSG00000144834; HGNC ID: 29868 |
Relate to Another Database: | SFARIGene; denovo-db |


>TAGLN3|29114|nucleotide
ATGGCTAACAGGGGCCCGAGCTATGGCTTAAGCCGAGAGGTGCAGGAGAAGATCGAGCAGAAGTATGATGCGGACCTGGAGAACAAGCTGGTGGACTGGATCATC
CTGCAGTGCGCCGAGGACATAGAGCACCCGCCCCCCGGCAGGGCCCATTTTCAGAAATGGTTAATGGACGGGACGGTCCTGTGCAAGCTGATAAATAGTTTATAC
CCACCAGGACAAGAGCCCATACCCAAGATCTCAGAGTCAAAGATGGCTTTTAAGCAGATGGAGCAAATCTCCCAGTTCCTAAAAGCTGCGGAGACCTATGGTGTC
AGAACCACCGACATCTTTCAGACGGTGGATCTATGGGAAGGGAAGGACATGGCAGCTGTGCAGAGGACCCTGATGGCTTTAGGCAGCGTTGCAGTCACCAAGGAT
GATGGCTGCTATCGGGGAGAGCCATCCTGGTTTCACAGGAAAGCCCAGCAGAATCGGAGAGGCTTTTCCGAGGAGCAGCTTCGCCAGGGACAGAACGTAATAGGC
CTGCAGATGGGCAGCAACAAGGGAGCCTCCCAGGCGGGCATGACAGGGTACGGGATGCCCAGGCAGATCATGTAG
Show »
ATGGCTAACAGGGGCCCGAGCTATGGCTTAAGCCGAGAGGTGCAGGAGAAGATCGAGCAGAAGTATGATGCGGACCTGGAGAACAAGCTGGTGGACTGGATCATC
CTGCAGTGCGCCGAGGACATAGAGCACCCGCCCCCCGGCAGGGCCCATTTTCAGAAATGGTTAATGGACGGGACGGTCCTGTGCAAGCTGATAAATAGTTTATAC
CCACCAGGACAAGAGCCCATACCCAAGATCTCAGAGTCAAAGATGGCTTTTAAGCAGATGGAGCAAATCTCCCAGTTCCTAAAAGCTGCGGAGACCTATGGTGTC
AGAACCACCGACATCTTTCAGACGGTGGATCTATGGGAAGGGAAGGACATGGCAGCTGTGCAGAGGACCCTGATGGCTTTAGGCAGCGTTGCAGTCACCAAGGAT
GATGGCTGCTATCGGGGAGAGCCATCCTGGTTTCACAGGAAAGCCCAGCAGAATCGGAGAGGCTTTTCCGAGGAGCAGCTTCGCCAGGGACAGAACGTAATAGGC
CTGCAGATGGGCAGCAACAAGGGAGCCTCCCAGGCGGGCATGACAGGGTACGGGATGCCCAGGCAGATCATGTAG
Show »


Click the link of the category-specific score to view different category of evidences. The categories without any evidences are hidden by default.
Evidences | Syndromic Gene | GWAS | CNV | Linkage | Association | Expression | NGS de novo | NGS Mosaic | NGS Other | Low-Scale Gene Studies | Total |
---|---|---|---|---|---|---|---|---|---|---|---|
Score (No. of Studies) | No | 0 (0) | 0 (0) | 1 (1) | 0 (0) | 2 (2) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 4 (3) |








Reference | Source | Method | ADI-R | ADOS | Diagnosis | Family | Individual | |||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Total | Simplex | Multiplex | Control | Affected | Control | Total | ||||||
Allen-Brady, 2008 | - | SNP-based genomic screen | ![]() | ![]() | ASD | 1 | - | 1 | - | 7 | 22 | 29 |




Microarray Studies: 2
Reference | Source | Tissue | #Subjects (% Women) |
ADI-R | ADOS | Endo- pheno | Diagnosis | Normal Controls (% Women) |
Fold Change | Up/ Down | P/Q value | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Voineagu, 2011_1 | Unknown | 16 frontal cortex(BA9) and 13 temporal cortex(BA41 | 16 (25.00%) | ![]() | ![]() | - | autism | 16 (6.25%) |
0.638468 | Down | 0.52772 | |
Voineagu, 2011_2 | Unknown | frontal, BA44/45 | 10 (0.00%) | ![]() | ![]() | - | autism | 6 (0.00%) |
0.705783 | Down | 0.0791835 |
Proteomics Studies:0
Reference | Source | Tissue | Platform | #Subjects (% Women) |
ADI-R | ADOS | Diagnosis | Normal Controls(% Women) | |
---|---|---|---|---|---|---|---|---|---|
No Evidence. |








Contact Us if you are an author of a study regarding this gene and do not find your study in this table or find errors in the representation of your study details.